Long-term safety, efficacy, and patient acceptability of teriparatide in the management of glucocorticoid-induced osteoporosis

References

• van StaaTPLeufkensHGAbenhaimLBegaudBZhangBCooperCUse of oral corticosteroids in the United KingdomQJM20009310511110700481
   PubMed Web of Science ®Google Scholar
• SaagKGlucocorticoid-induced osteoporosisEndocrinol Metab Clin North Am20033213515712699296
   PubMed Web of Science ®Google Scholar
• CanalisEMazziottiGGiustinaABilezikianJPGlucocorticoid-induced osteoporosis: pathophysiology and therapyOsteoporos Int2007181319132817566815
   PubMed Web of Science ®Google Scholar
• AdlerRACurtisJRWeinsteinRSSaagKGlucocorticoid-induced osteoporosisFeldmanDMarcusRNelsonDRosenCJOsteoporosis3rd edSan DiegoElsevier-Academic Press200811351166
   Google Scholar
• Van StaaTPLaanRFBartonIPCohenSReidDMCooperCBone density threshold and other predictors of vertebral fracture in patients receiving oral glucocorticoid therapyArthritis Rheum2003483224322914613287
   PubMed Web of Science ®Google Scholar
• Van StaaTPLeufkensHGCooperCThe epidemiology of corticosteroid-induced osteoporosis. a meta-analysisOsteoporos Int20021377778712378366
   PubMed Web of Science ®Google Scholar
• LoCascioVBonucciEImbimboBBone loss in response to long-term glucocorticoid therapyBone Miner1990839512306553
   PubMedGoogle Scholar
• GrossmanJMGordonRRanganathVKAmerican College of Rheumatology 2010 Recommendations for the Prevention and Treatment of Glucocorticoid-Induced OsteoporosisArthritis Care Res (Hoboken)2010621515152620662044
   PubMed Web of Science ®Google Scholar
• Bone and Tooth Society of Great Britain, National Osteoporosis Society, Royal College of PhysiciansGlucocorticoid-Induced Osteoporosis: Guidelines for Prevention and TreatmentLondonRoyal College of Physicians2002 Available from: http://bookshop.rcplondon.ac.uk/contents/966c62dd-8011-4f65-a61d-dd0c7fe4fa4b.pdfAccessed February 21, 2013
   Google Scholar
• CurtisJRWestfallAOAllisonLLLongitudinal patterns in the prevention of osteoporosis in glucocorticoid-treated patientsArthritis Rheum2005522485249416052570
   PubMed Web of Science ®Google Scholar
• BlalockSJNortonLLPatelRADooleyMAPatient knowledge, beliefs and behavior concerning the prevention and treatment of glucocorticoid-induced osteoporosisArthritis Rheum20055373273916208664
   PubMed Web of Science ®Google Scholar
• Warner-ChilcottActonel (risedronate) [package insert]Rockaway (NJ)Warner-Chilcott
   Google Scholar
• Novartis PharmaceuticalsReclast (zoledronic acid) [package insert]East Hanover (NJ)Novartis Pharmaceuticals
   Google Scholar
• MerckFosamax (alendronate) [package insert]Whitehouse Station (NJ)Merck
   Google Scholar
• EliLillyForteo (teriparatide) package insertIndianapolisEli Lilly
   Google Scholar
• CanalisEBilezikianJPAngeliAPerspectives on glucocorticoid-induced osteoporosisBone20043459359815050888
   PubMed Web of Science ®Google Scholar
• DoreRKHow to prevent glucocorticoid-induced osteoporosisCleve Clin J Med20107752953620682515
   PubMed Web of Science ®Google Scholar
• BeavanSHornerABordSIrelandDCompstonJColocalization of glucocorticoid and mineralocorticoid receptors in human boneJ Bone Miner Res2001161496150411499872
   PubMed Web of Science ®Google Scholar
• CooperMSHewisonMStewardPMGlucocorticoid activity, inactivity and the osteoblastJ Endocrinol199916315916410556763
   PubMed Web of Science ®Google Scholar
• WeinsteinRSGlucocorticoid-induced osteoporosisRev Endocr Metab Disord20012657311708295
   PubMedGoogle Scholar
• BuxtonECYaoWLaneNEChanges in serum receptor activator of nuclear factor-kappa beta ligand, osteoprotegerin, and interleukin-6 levels in patients with glucocorticoid-induced osteoporosis treated with human parathyroid hormone (1–34)J Clin Endocrinol Metab2004893332333615240611
   PubMed Web of Science ®Google Scholar
• LiuYPortaAPengXPrevention of glucocorticoid-induced apoptosis in osteocytes and osteoblasts by calbindin-D28kJ Bone Miner Res20041947949015040837
   PubMed Web of Science ®Google Scholar
• YunSIYoonHYJeongSYChungYSGlucocorticoid induces apoptosis of osteoblast cells through the activation of glycogen synthase kinase 3betaJ Bone Miner Metab20092714014819066717
   PubMed Web of Science ®Google Scholar
• OhnakaKTanabeMKawateHNawataHTakayanagiRGlucocorticoid suppresses the canonical Wnt signal in cultured human osteoblastsBiochem Biophys Res Commun200532917718115721290
   PubMed Web of Science ®Google Scholar
• ShiXMBlairHCYangXMcDonaldJMCaoXTandem repeat of C/EBP binding sites mediates PPARgamma2 gene transcription in glucocorticoid-induced adipocyte differentiationJ Cell Biochem20007651852710649448
   PubMed Web of Science ®Google Scholar
• Carcamo-OriveIGaztelumendiADelgadoJRegulation of human bone marrow stromal cell proliferation and differentiation capacity by glucocorticoid receptor and AP-1 crosstalkJ Bone Miner Res2010252115212520499359
   PubMed Web of Science ®Google Scholar
• LaneNEYaoWBaloochMGlucocorticoid-treated mice have localized changes in trabecular bone material properties and osteocyte lacunar size that are not observed in placebo-treated or estrogen-deficient miceJ Bone Miner Res20062146647616491295
   PubMed Web of Science ®Google Scholar
• MizushimaNLevineBCuervoAMKlionskyDJAutophagy fights disease through cellular self-digestionNature20084511069107518305538
   PubMed Web of Science ®Google Scholar
• XiaXKarRGluhak-HeinrichGlucocorticoid-induced autophagy in osteocytesJ Bone Miner Res2010252479248820564240
   PubMed Web of Science ®Google Scholar
• SaagKGShaneEBoonenSTeriparatide or alendronate in glucocorticoid-induced osteoporosisN Engl J Med20073572028203918003959
   PubMed Web of Science ®Google Scholar
• DoggettTASwarthoutJTJefcoatSCJrParathyroid hormone inhibits c-jun N terminal kinase activity in rat osteoblastic cells by a protein kinase A-dependent pathwayEndocrinology20021431880188811956171
   PubMed Web of Science ®Google Scholar
• SabatiniMLesurCPacherieMEffects of parathyroid hormone and agonists of the adenylyl cyclase and protein kinase C pathways on bone cell proliferationBone19961859658717538
   PubMed Web of Science ®Google Scholar
• DobnigHTurnerRTEvidence that intermittent treatment with parathyroid hormone increases bone formation in adult rats by activation of bone lining cellsEndocrinology1995136363236387628403
   PubMed Web of Science ®Google Scholar
• JilkaRLMolecular and cellular mechanisms of the anabolic effect of intermittent PTHBone2007401434144617517365
   PubMed Web of Science ®Google Scholar
• JilkaRLO’BrienCAAliAARobersonPKWeinsteinRSManolagasSCIntermittent PTH stimulates periosteal bone formation by actions on post-mitotic preosteoblastsBone20084427528619010455
   PubMed Web of Science ®Google Scholar
• JilkaRLWeinsteinRSBellidoTRobersonPParfittAMManolagasSCIncreased bone formation by prevention of osteoblast apoptosis with parathyroid hormoneJ Clin Invest199910443944610449436
   PubMed Web of Science ®Google Scholar
• DattaNSPettwayGJChenCKohAJMcCauleyLKCyclin D1 as a target for the proliferative effects of PTH and PTHrP in early osteoblastic cellsJ Bone Miner Res20072295196417501623
   PubMed Web of Science ®Google Scholar
• CanalisEGiustinaABilezikianJPMechanisms of anabolic therapies for osteoporosisN Engl J Med200735790591617761594
   PubMed Web of Science ®Google Scholar
• KakarSEinhornTAVoraSEnhanced chondrogenesis and Wnt signaling in PTH-treated fracturesJ Bone Miner Res2007221903191217680724
   PubMed Web of Science ®Google Scholar
• BodinePVSeestaller-WehrLKharodeYPBexFJKommBSBone anabolic effects of parathyroid hormone are blunted by deletion of the Wnt antagonist secreted frizzled-related protein-1J Cell Physiol200721035235717044082
   PubMed Web of Science ®Google Scholar
• YaoWChengZPhamAGlucocorticoid-induced bone loss can be reversed by the actions of PTH and risedronate on different pathways for bone formation and mineralizationArthritis Rheum2008583485349718975341
   PubMed Web of Science ®Google Scholar
• DevogelaerJPAdlerRARecknorCBaseline glucocorticoid dose and bone mineral density response with teriparatide or alendronate therapy in patients with glucocorticoid-induced osteoporosisJ Rheumatol20103714114819918047
   PubMed Web of Science ®Google Scholar
• SaagKGZanchettaJRDevogelaerJPEffects of teriparatide versus alendronate for treating glucocorticoid-induced osteoporosis: thirty-six-month results of a randomized, double-blind, controlled trialArthritis Rheum2009603346335519877063
   PubMed Web of Science ®Google Scholar
• LangsdahlBLMarinFShaneETeriparatide versus alendronate for treating glucocorticoid-induced osteoporosis:an analysis by gender and menopausal statusOsteoporos Int2009202095210419350340
   PubMed Web of Science ®Google Scholar
• LosadaBRZanchettaFRZerbiniCActive comparator trial of teriparatide vs alendronate for treating glucocorticoid-induced osteoporosis: results from the Hispanic and non-Hispanic cohortsJ Clin Densitom200912637019028124
   PubMed Web of Science ®Google Scholar
• GluerCCMarinFRingeJDComparative effects of teriparatide and risedronate in glucocorticoid-induced osteoporosis in men: 18 month results of the EuroGIOPS trialJ Bone Miner Res Epub1152013
   Web of Science ®Google Scholar
• World Health OrganizationCollaborating Centre for Metabolic Bone DiseasesFRAXWHO fracture risk assessment tool Available from: http://www.shef.ac.uk/FRAXAccessed February 21, 2013
   Google Scholar
• HansenKEWilsonHAZapalowskiCFinkHAMinisolaSAdlerRAUncertainties in the prevention and treatment of glucocorticoid-induced osteoporosisJ Bone Miner Res2011261989199621721042
   PubMed Web of Science ®Google Scholar
• [No authors listed]Recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis: 2001 update. American College of Rheumatology Ad Hoc Committee on Glucocorticoid-Induced OsteoporosisArthritis Rheum2001441496150311465699
   PubMed Web of Science ®Google Scholar
• GoldDTWeinsteinDLPohlGKrohnKDChenYMeadowsESFactors associated with persistence with teriparatide therapy: results from the DANCE observational studyJ Osteoporos2011201131497022013544
   PubMedGoogle Scholar
• MillerPDSilvermanSLGoldDTTaylorKAChenPWagmanRBRationale, objectives and designs of the Direct Analysis of Nonvertebral Fracture in the Community Experience (DANCE) studyOsteoporos Int200617859015981021
   PubMed Web of Science ®Google Scholar
• BrodMRousculpMCameronAUnderstanding compliance issues for daily self-injectable treatment in ambulatory care settingsPatient Prefer Adherence2008212913619920953
   PubMedGoogle Scholar
• FranceschettiPAmbrosioMZatelliMEfficacy, safety and adherence to treatment of teriparatide: an observational studyEndocr Abstr201229190
   Google Scholar
• ZillerVZimmermannSPKalderMAdherence and persistence in patients with severe osteoporosis treated with teriparatideCurr Med Res Opin20102667568120078188
   PubMed Web of Science ®Google Scholar
• Hazel-FernandezLLouderAMFosterSAUribeCLBurgeRTAssociation of teriparatide adherence and persistence with clinical and economic outcomes in Medicare Part D recipients: a retrospective cohort studyBMC Musculoskelet Disord201314423281846
   PubMed Web of Science ®Google Scholar
• FosterSAFoleyKAMeadowsESAdherence and persistence with teriparatide among patients with commercial, Medicare and Medicaid insuranceOsteoporos Int20112255155720798929
   PubMed Web of Science ®Google Scholar
• HalpernRBeckerLIqbalSUKazisLEMacariosDBadamgaravEThe association of adherence to osteoporosis therapies with fracture, all-cause medical costs, and all-cause hospitalizations: a retrospective claims analysis of female health plan enrollees with osteoporosisJ Manag Care Pharm201117253921204588
   PubMed Web of Science ®Google Scholar
• SolomonDHKatzJNJacobsJPLa TouretteAMCoblynJManagement of glucocorticoid-induced osteoporosis in patients with rheumatoid arthritisArthritis Rheum2002463136314212483716
   PubMed Web of Science ®Google Scholar
• NauntonMPetersonGMJonesGGriffinGMBleaselMDMultifaceted educational program increase prescribing of preventive medication for corticosteroid induced osteoporosisJ Rheumatol20043155055614994404
   PubMed Web of Science ®Google Scholar
• SolomonDHKatzJNLa TouretteAMCoblynJSMultifaceted intervention to improve rheumatologists’ management of glucocorticoid-induced osteoporosis: a randomized controlled trialArthritis Rheum20045138338715188323
   PubMed Web of Science ®Google Scholar
• NewmanEDMatzkoCKOlenginskiTPGlucocorticoid-Induced Osteoporosis Program (GIOP): a novel, comprehensive and highly successful care program with improved outcomes at 1 yearOsteoporos Int2006171428143416865312
   PubMed Web of Science ®Google Scholar
• EliLillyForteo2011 Available from: http://www.forteo.comAccessed February 21, 2013
   Google Scholar
• TeitelbaumSLSetonMPSaagKGShould bisphosphonates be used for long-term treatment of glucocorticoid-induced osteoporosis?Arthritis Rheum20116332532821279986
   PubMed Web of Science ®Google Scholar